FENOPROFEN CALCIUM Drug Patent Profile
✉ Email this page to a colleague
When do Fenoprofen Calcium patents expire, and when can generic versions of Fenoprofen Calcium launch?
Fenoprofen Calcium is a drug marketed by Am Therap, Halsey, Misemer, Par Pharm, Quantum Pharmics, Rising, Warner Chilcott, Watson Labs, Ani Pharms, Dava Pharms Inc, Ivax Sub Teva Pharms, Pharmaco, Strides Pharma Intl, Sun Pharm Industries, Usl Pharma, and Watson Labs Teva. and is included in thirty-two NDAs.
The generic ingredient in FENOPROFEN CALCIUM is fenoprofen calcium. There are nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the fenoprofen calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fenoprofen Calcium
A generic version of FENOPROFEN CALCIUM was approved as fenoprofen calcium by RISING on July 18th, 2022.
